-
‘This Is Us' Raises Awareness About Alzheimer's Disease
The final season of “This Is Us” has focused on the matriarch of the Pearson family – Rebecca’s battle with Alzheimer’s disease and how the family has reacted. News4’s Doreen Gentzler spoke to Ana Nelson with the Alzheimer’s Association National Capital Area Chapter about the show’s depiction of the disease and how families can get help with treatment and resources....
-
Medicare Weighs Premium Cut After Limiting Alzheimer's Drug
Medicare says it’s considering a cut in enrollee premiums, after officials stuck with an earlier decision to sharply limit coverage for a pricey new Alzheimer’s drug projected to drive up program costs
-
Medicare Limits Coverage of $28,000-A-Year Alzheimer's Drug
Medicare says it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned
-
Medicare Told to Reassess Premium Hike for Alzheimer's Drug
U.S. health secretary Xavier Becerra is ordering Medicare to reassess a big premium increase facing millions of seniors this year
-
Why Biogen's Alzheimer's Drug Aduhelm Is So Controversial
Biogen’s Alzheimer’s drug Aduhelm was heralded as a historic triumph against the memory-robbing disease. Now, the company is trying to keep it afloat.
-
Waiting to Talk Finance With an Aging Parent in Cognitive Decline Is a Mistake, Experts Say
Waiting to talk to an aging parent about their financial future until they experience cognitive decline is a mistake, say financial advisors.
-
ATM Attack and Alzheimer's Treatment Trial: The News4 Rundown
A retired news photographer in D.C. is now seeking justice after charges against someone who attacked him were dropped, an Alzheimer’s disease treatment that just entered clinical phases could be a breakthrough for one of the world’s most notorious diseases, and some food for thought that could help keep off those extra holiday pounds.
-
Financial Scam Serves as Warning for Those Seeking a Caregiver for Older Relatives
Billions of dollars are stolen from seniors each year. Financial fraud and exploitation is the most prevalent form of elder abuse.
-
First Human Trial of Alzheimer's Nasal Vaccine to Begin in Boston
Brigham and Women’s Hospital is launching the first human clinical trial for a nasal vaccine for Alzheimer’s disease.
-
Woman Convinced Husband He Had Alzheimer's, Then Stole $600K: PD
A Connecticut woman was arrested Wednesday, accused of stealing $600,000 from her husband by convincing him he had Alzheimer’s disease in order to hide it from him, police said.
-
In Quiet Debut, Alzheimer's Drug Finds Questions, Skepticism
Persistent concerns about the first new Alzheimer’s treatment in more than 20 years are curbing access more than four months after regulators approved it.
-
A Harvard Nutritionist and Brain Expert Shares the 5 Foods She Eats Every Day to Sharpen Her Memory and Focus
A daily diet of colorful fruits and vegetables can help make your brain strong, sharper and smarter, studies show. Here’s what a Harvard nutritional psychiatrist eats to strengthen her memory, focus and overall health.
-
Christa Beverly Baker, Wife of Former County Executive, Dies at 61
Former Prince George’s County Executive Rushern Baker announced that he lost “the love of my life,” his wife Christa, on Saturday, Sept. 18. 2021.
-
Christa Beverly Baker, Wife of Former Prince George's County Executive, Dies at 61
Christa Beverly Baker, the wife of former Prince George’s County Executive Rushern Baker, died Saturday after “fighting illness with grace and grit,” her husband said. She was 61. “Today I lost the love of my life, my best friend, and the source of all my strength. She was our rock – the absolutely best mother to my kids and wife…
-
FDA Sets Limits for Controversial Alzheimer Drug, Calls for Investigation
A month after approving a controversial new Alzheimer’s drug, the FDA has signed off on new prescribing instructions to limit its use to only patients with early or mild cases of the disease. The acting head of the FDA, Dr. Janet Woodcock, also announced that she was ordering an investigation into whether the agency acted improperly in approving the...
-
FDA Head Calls for Probe Into Approval of Alzheimer's Drug Aduhelm
The acting head of the Food and Drug Administration is calling for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug
-
Alzheimer's Drug Stirs Hope for Patients, Worry for Doctors
Doctors are trying to figure out who should get a new treatment for Alzheimer’s disease
-
Biogen Alzheimer's Drug and the Battle Over Dementia Treatment of the Future
Biogen Alzheimer’s drug Aduhelm is the first new treatment for dementia approved by the FDA in decades, and it’s started a war over the brain drug pipeline.
-
Here's How Insurers May Cover That Expensive New Alzheimer's Drug
Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment
-
FDA Approves Much-Debated Alzheimer's Drug Panned by Experts
Government health officials have approved the first drug that they say may help slow Alzheimer’s disease